MarginsXMarginsX
Home › Markets › Health Care › ESYN

EnerSyn Global Inc. (ESYN)

ESYN trades on Nasdaq in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.25
0.00% on the day
Market cap
$37.2M
Nano cap
Revenue · 2025
$867K
-30.8% on 2024
Net income · 2025
-$2.6M
-303.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1897245/000149315226012738/0001493152-26-012738-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerESYN on Nasdaq
SectorHealth Care
IndustryOther Pharmaceuticals
CountryUnited States
IPO year2022
SEC CIK0001897245
SEC industry codeWholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated inNV

Financials · 2025

LineValue
Revenue$867K
Net income-$2.6M
Operating incomeNot in SEC XBRL data
Net margin-303.4%
Operating marginOperating income not reported
Revenue growth-30.8%
Cash$2.1M
Total assets$4.6M
P/E (computed)Net income was not positive
P/S (computed)42.9×

Warning signs

Cash runway
19.3 months
$1.5M cash at June 30, 2026
Share count, 1 year
+420.8%
2025-10-21 to 2026-11-13 · +939.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$402K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about our ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$1.5M cash; operating cash flow -$234K a quarter.Report 2026-06-30
Shares outstanding33,726,400 (2026-11-13); 6,476,400 a year earlier; 16,223,301 three years earlier. 3y figure adjusted for split (1-for-5 overall).Cover page 2026-11-13
Reverse splits, 3 years1; latest 1-for-5 on 2025-02-24Source 2025-02-24
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-05-29
AuditorHTL International, LLC, Houston, Texas, United States; changed auditors 1 time in 24 months8-K 4.01 2025-07-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $500K, sold $98K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$64K$212K$478K$1.5M$22K$390K10-Q 2026-07-30
Q1 2026
2026-03-31
$64K-$626K-$193K$1.5M$259K$636K10-Q 2026-05-13
Q4 2025
2025-12-31
$55K-$1.9M-$1.0M$2.1M$259K$867K10-K 2026-03-26
Q3 2025
2025-09-30
$207K-$291K-$200K$2.9M$975K$1.1M10-Q 2025-10-22
Q2 2025
2025-06-30
$310K$83K$27K$3.7M$976K$1.2M10-Q 2026-07-30
Q1 2025
2025-03-31
$295K-$565K-$555K$4.2M$982K$1.3M10-Q 2026-05-13
Q4 2024
2024-12-31
$287K-$477K-$415K$4.3M$1.2M$1.3M10-K 2026-03-26
Q3 2024
2024-09-30
$346K-$548K-$275K$832K$270K$967K10-Q 2025-10-22

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-01-06
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-09-18
Latest proxyDEFA14A2026-10-27

Source: SEC EDGAR submissions feed, 272 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-23.3%
1 month-38.4%
3 months-26.0%
Year to date-16.1%
1 year-29.0%
From 52-week high-53.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Other Pharmaceuticals

TickerCompanyPriceDayMarket cap
ZSTKZeroStack Corp.$2.80-1.75%$61.1M
NUSNu Skin Enterprises Inc.$3.93-2.48%$191.3M
COSMCosmos Health Inc.$2.49-23.15%$250.6M
HKPDCellyan Biotechnology Co. Ltd$1.61-0.62%$4.0M
MEDSDataMeds AI Inc.$0.6421-13.68%$3.1M
HLFHerbalife Ltd. Common Shares$16.15+1.19%$1.7B
CAHCardinal Health Inc.$283.85+0.98%$65.6B
CORCencora Inc.$356.94-0.58%$68.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier